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A B S T R A C T
Purpose: Our study aims to test the prognostic accuracy of the N parameter of the 7th TNM in aWestern series
of D1-gastrectomies for gastric cancer (GC).
Methods: Retrospectively considering a series of 224 non-metastatic GC patients who underwent surgery
with curative intent and limited lymphadenectomy, we analyzed 5-year overall survival (OS) related to
pN status according to both TNMeditions (pN6 andpN7) and to lymphnode ratio (LNR; LNR0, 0%, LNR1, 1–19%;
LNR2, >20%). We stratiﬁed pN6- and pN7-related OS by LNR.
Results: Both pN6 and pN7 were shown to signiﬁcantly stratify different subsets of GC patients, but there was
no signiﬁcant difference between pN71 and pN72, nor between pN62 and pN63. Amultivariatemodel speciﬁc
for pN7 eliminated the N2 group, while the pN6 model maintained all 3 N groups with highly discriminating
hazard ratios. LNRwas able to further stratify one category of pN6 (N2) and two categories of pN7 (N1 andN2).
Conclusions: The 7th TNM edition for GC does not seem to be superior to the 6th edition in evaluating the
prognostic relevance of lymph-nodal status: in particular, it does not allow an accurate stratiﬁcation of OS in
patients with less than 6 positive lymph nodes.
© 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
1. Introduction
Lymph nodemetastases are considered to be one of themost relevant
prognostic factors in gastric cancer patients. 1,2 In the seventh edition
of the TNM staging system for gastric cancer, the classiﬁcation of
the number of regional involved lymph nodes (N) has been revised
into the conventional four categories N0, N1, N2 and N3, according
to new cutoffs, in order to improve its reproducibility and prognostic
validity. 3 Actually, although supported by literature, 2,4,5 the reduced
cutoffs seem to be in contrast with the suggested principles of
extended lymphadenectomy. 6 Although the UICC recommends a
minimumnumber of 16 lymphnodes to be removed, the latest edition
of the TNM gives the possibility of discriminating between different
prognostic categories even when a very limited lymphadenectomy
is performed (e.g., to distinguish between the N1 and N2 groups by
only 3 analyzed nodes). Hence, the reduction of the number of lymph
nodes to be removed appears consistent with the poor diffusion of
extended lymphadenectomy in Western countries, but its prognostic
capability remains doubtful.
The aimof this study is to verify the staging efﬁcacy of the newNpa-
rameter in a consecutive series of gastric cancer patients undergoing
surgery with curative intent and limited lymphadenectomy.
2. Patients and methods
2.1. Patients
Clinical data have been collected from case sheets and from
the histological exams of the specimens. Between January 1995
and December 2011, 224 patients with non-metastatic gastric
adenocarcinoma underwent surgery with curative intent. Subtotal
gastrectomy was performed in most cases (53.6%). Multivisceral
resection was required in 11 (4.9%) patients for suspected T4 tumors.
Two hundred and thirteen patients (95.1%) underwent a limited
lymphadenectomy (D1); a more extended lymphadenectomy (D2)
was performed in 11 cases (4.9%)with evident lymphnodemetastases
in second level lymph node stations. For the analysis we considered
the following factors: patient’s age and gender; tumor location
(1/3 proximal versus 2/3 distal); type of surgery (total versus
subtotal gastrectomy), number of nodes removed, and intraoperative
blood transfusions; residual tumor (R), tumor diameter, Lauren’s
classiﬁcation, Borrmann’s classiﬁcation, grading of differentiation (G),
pT classiﬁed according to the seventh TNM edition, 3 pN classiﬁed
according to both the sixth (pN6) 7 and the seventh (pN7) 3 TNM, and
lymph node ratio (LNR0, 0; LNR1, <20%; LNR2,20%). Retrospectively,
we considered cancer-related death as the end-point to evaluate rates
of overall survival (OS).
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Table 1
Clinical and pathological features. Overall survival rates and univariate analysis of the sample.
Variable Number % 5-year OS (%) p-value
Age (years) 0.518
67 108 48.2 75.9
>67 116 51.8 73.3
Gender 0.544
M 147 65.6 74.3
F 77 34.4 34.4
Tumor location 0.961
1/3 proximal 47 21.1 74.6
2/3 distal 176 78.9 74.8
Type of gastrectomy 0.614
Total 104 46.4 74.5
Subtotal 120 53.6 75.2
Number of lymph nodes removed 0.122
<16 92 41.1 72.0
16 132 58.9 77.0
Peri-operative blood transfusions 0.026
Yes 46 20.6 64.7
No 178 79.4 77.0
R <0.001
0 205 91.8 79.0
1–2 19 8.2 38.7
Tumor diameter (mm) 0.01
40 138 58.9 83.4
>40 86 41.1 63.1
Lauren’s classiﬁcation 0.081
Diffuse 122 54.5 69.3
Intestinal 102 45.5 81.8
Borrmann’s classiﬁcation 0.016
1 8 5.1 100
2 58 36.9 79.6
3 79 50.3 62.7
4 12 7.6 42.4
Grading 0.026
1 10 4.5 100
2 95 43.0 82.1
3 119 52.5 69.3
pT <0.001
1a 33 14.8 97.0
1b 33 14.8 95.8
2 26 11.6 87.1
3 80 35.7 66.6
4a-b 52 23.1 53.9
pN6 (2002) <0.001
0 99 44.2 94.8
1 85 37.9 70.9
2 27 12.1 35.0
3 13 5.8 22.0
pN7 (2010) <0.001
0 99 44.2 94.8
1 43 19.2 74.4
2 42 18.7 76.7
3a 27 12.1 36.7
3b 13 5.8 20.1
Lymph node ratio (LNR) <0.001
0 99 44.2 94.8
<20% 57 25.5 79.7
20% 68 30.3 38.8
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2.2. Statistical analysis
All variables were expressed as mean ± standard deviation (SD) or
median and range. Continuous variables were categorized around
their median value or a well-known cutoff. Survival was calculated
from the day of surgery until June 2011 (actuarial OS). Patients who
died of non-cancer-related causes were censored at the time of death.
Survival rates were calculated by the Kaplan–Meier method and
log-rank test was used for univariate analysis. The Cox proportional
hazard model was used for multivariate analysis, including only
variables with p < 0.1 at log-rank test, with a backward elimination
model for all covariates. Hazard ratio (HR) and 95% conﬁdence
interval (CI) were calculated in the model for each variable included.
The regression model was controlled with goodness of ﬁt tests. In
order to avoid co-linearity problemswe used two differentmodels for
the multivariate analysis: one for pN6 and another for pN7. p < 0.05
was considered statistically signiﬁcant. All statistical analyses were
performed using the Statistical Package for Social Sciences (SPSS)
version 13.0 for Windows©.
3. Results
The mean number of lymph nodes harvested was 19.3±12.1, and the
mean number ofmetastatic lymph nodeswas 3.4±5.5: 99 patients out
of 224 (44.2%) had no metastatic lymph nodes.
After a median follow up of 48.0 months, 50 (22.3%) patients
had died from gastric cancer. Overall survival at 12, 24, 36, 48 and
60 months was, respectively, 96.2%, 87.2%, 80.0%, 74.9% and 74.1%.
Clinical and pathological characteristics of the sample with survival
rates and univariate analysis are reported in Table 1. In particular,
pN6 and pN7, as well as LNR, signiﬁcantly stratiﬁed patients with
different OS (all p < 0.001). Applying the log-rank test to each stratum
of both pN6 and pN7, we observed that pN6 showed a loss of
statistical signiﬁcance between pN62 and pN63 patients (p = 0.127)
(Fig. 1) and, similarly, pN7 showed a loss of statistical signiﬁcance
between pN71 and pN72 patients (p = 0.844) (Fig. 2). Moreover,
stratifying each pN category according to LNR only one pN6 group
(pN61, with p =0.012) (Fig. 3) and two pN7 categories (pN71 and
pN72, with p = 0.07 and p=0.04, respectively) were further stratiﬁed
(Fig. 4). Cox regression selected lymph node status as the only
Fig. 1. Overall survival according to pN6 staging.
Fig. 2. Overall survival according to pN7 staging.
Fig. 3. Overall survival of pN61 patients stratiﬁed by lymph node ratio (LNR).
Fig. 4. Overall survival of pN72 patients stratiﬁed by lymph node ratio (LNR).
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Table 2
Multivariate analysis by Cox regression
pN Hazard
ratio
p-value
(A) Model including pN6 (goodness of the model:
−2 Log likelihood, 172.555; c2, 67.290; P< 0.00001)
pN6 (2002)
0 1 −
1 10.79 0.002
2 120.14 <0.001
3 376.91 <0.001
(B) Model including pN7 (goodness of the model:
−2 Log likelihood, 171.862; c2, 60.387; P < 0.00001).
pN7 (2010)
0 1 −
1 10.20 0.004
2 4.553 0.73
3 49.36 <0.001
independent signiﬁcant prognostic factor, in both the pN6 and the
pN7 model (Table 2). However, while pN6 kept all of its categories
with high HRs until the last step of the multivariate analysis, pN7 lost
its pN2 category at the last step, and its model resulted in less
relevant HRs (Table 2).
4. Discussion
Many efforts have beenmade to reach a higher accuracy in the staging
of the N parameter, since regional lymph node metastases are one of
the variables inﬂuencing treatment strategy. At present, the clinical
evaluation of lymph node status by imaging is still unreliable, 8 and
many controversies remain about its pathological staging too. A shift
occurred in 1997 from an anatomic to a numeric criterion for pN,
on the basis of a presumed better prognostic stratiﬁcation, and this
necessarily required the introduction of arbitrary cutoffs, 9 validated
on the simple basis of statistical observations. For the ﬁrst time since
then, the seventh TNM edition modiﬁed these cut-offs: pN61 (1–6
positive regional lymph nodes) was divided into new groups pN71
(1–2 positive regional lymph nodes) and pN72 (3–6 positive regional
lymph nodes), while pN62 (7–15 positive regional lymph nodes) and
pN63 (>15 positive regional lymph nodes) were united into the new
pN73 group (>6 positive regional lymph nodes). 3 Even though the
recommended minimum number of lymph nodes to be removed has
increased to 16, 3 the possibility of discriminating different tumor
stages even by few harvested nodes seems to satisfy the principles
of reproducibility and standardization needed to obtain comparable
survival curves worldwide. In fact, an ideal staging system should be
independent of the type of treatment and be able to correctly stratify
different prognostic groups too.
The literature presents only few contributions, with controversial
results, about comparison between the sixth and the seventh TNM.
Ahn et al., analyzing survival of 9998 patients having undergone
R0 gastrectomy, and considering only patients with 15 or more
retrieved lymph nodes, maintain that the new TNM edition shows a
more detailed classiﬁcation of different prognostic groups, especially
for pN71 and pN72 patients (p = 0.0018), and an increased homo-
geneity in each TNM stage. 4 Similarly, Wang et al., analyzing 1503
patients who underwent limited or extended lymphadenectomy,
with less than 15 harvested nodes on average, conﬁrm a better
prognostic stratiﬁcation of the latest TNM edition; however, they
state that subdividing the pN3 category into pN3a and pN3b may
be unnecessary. 5 Similar conclusions derive from the study by Fang
et al., as they obtained signiﬁcant differences in 5-year OS rates for the
pN1 and pN2 groups among 1380 patients who underwent D1a/D2
gastrectomy, and classiﬁed according to the seventh edition (71.4% vs
44.1%, p < 0.001). 10 Consistently, Chae et al. report for the seventh
TNMmore reliable prognostic results than for the sixth, analyzing 295
patients who underwent D2 gastrectomy and excluding patients with
less than 15 retrieved nodes. 2 Finally,McGhan et al., in a retrospective
review of gastric cancer patients from Surveillance, Epidemiology
and End Results Registry data, considering 3-year survival in 13,547
cases without any speciﬁcations about lymphadenectomy, afﬁrm
that the latest TNM has a better survival discrimination and risk
stratiﬁcation. 11 On the contrary, analyzing 1000 patients (49% with
less than 15 harvested nodes), Qiu et al. did not observe a superior
prognostic power of the seventh TNM edition in comparison to the
sixth edition. 12 Jung et al. propose a hybrid TNM classiﬁcation, using
the seventh edition for T classiﬁcation, and the sixth for N, as they
observed a low power of discrimination between pN71 and pN72,
which may result in unwarranted stage migration. 13 Kikuchi et al.,
analyzing 609 patients with advanced gastric cancer, state that the
seventh TNM is not always superior to the previous edition, even after
an extended lymphadenectomy. 14
In our study we aimed to verify the efﬁcacy of the latest TNM
in a series of limited lymphadenectomies, typical of the Western
world. Actually, our study conﬁrmed the relevant and independent
prognostic role of lymph node status despite the classiﬁcation
(Table 2 and Figs. 1, 2). Therefore, potentially, our series of limited
lymphadenectomies could be an ideal sample for testing the staging
efﬁcacy of the new cutoffs; our results justiﬁed the merging of
pN62 and pN63, but surprisingly they did not show any statistically
signiﬁcant OS differences between pN71 and pN72 patients (74.4% vs
76.7%) (Fig. 2). Additionally, in our series, the multivariate analysis
(which has not always been considered in other similar studies
published so far) selected all of the three N categories only for pN6, by
highly discriminating HRs, differently from themodel speciﬁc for pN7
(Table 2).
Furthermore, we aimed to verify the prognostic power of both
staging systems using LNR, a potential measure of lymphadenectomy
and a well-known predictor of survival. 1,15–17 Even in a series of
limited lymphadenectomies, LNR signiﬁcantly stratiﬁes the seventh
TNM, demonstrating its prognostic superiority on it. Amazingly, we
observed that stratiﬁcation by metastatic LNR almost reached or
reached statistical signiﬁcance in discriminating OS right in the newly
introduced groups pN71 and pN72 (Fig. 4). Consistently with these
data, Wang et al., comparing the latest TNM to a staging system
including LNR, observed that LNR staging shows superiority to the
7th edition of pN staging in a series of 1343 D2 gastrectomies. 18
Indeed, the inﬂuence of metastatic LNR on the new N staging system
may suggest that the latest TNM edition also might be affected by the
extension of lymphadenectomy with the potential exposure risk to
stage migration phenomenon.
4.1. Limitations of the study
Five-year survival rates reported in this study could appear much
better than in other Western series, but patients included in the
analysis were not selected. Moreover, because of the retrospective
nature of our study, not all data for each variable are available in
every analysis: the reported rates refer to samples where all data are
available. Although UICC/AJCC recommend a minimum number of 16
lymph nodes to be retrieved, 3 we decided to include also patients
who underwent a lymphadenectomy with less than 16 harvested
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nodes for deriving data from a real-world analysis, adherent to West-
ern attitudes and to some previous contributions. 5,12 Consistently,
in order to evaluate the real impact of the new staging system, we
chose to adjust the analysis for residual tumor factor too and therefore
R+ patients have not been excluded.
5. Conclusion
Our analysis has not found any prognostic superiority of the seventh
TNM edition with respect to the N parameter in comparison to
the sixth edition. The best possible prognostic stratiﬁcation and
the stage migration phenomenon are still a matter of debate, with
the TNM staging system apparently dependent on the type of
treatment. Hence, the new cutoffs can be considered a compromise
between extent of surgery and conventional numeric criterion. 6 At
the moment, its “few theoretical defects” 19 seem to compromise a
reliable prognostic prediction, at least in some smallWestern series of
gastric cancer patients who underwent limited lymphadenectomy.
Funding
None.
Disclosure statement
The authors have no conﬂicts of interest to declare.
References
1. Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric
cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998;228:
449–61.
2. Chae S, Lee A, Lee J. The effectiveness of the new (7th) UICC N classiﬁcation in
the prognosis evaluation of gastric cancer patients: a comparative study between
5th/6th and 7th UICC N classiﬁcation. Gastric Cancer 2011;14:166–71.
3. Sobin LH, Gospodarowicz MK, Wittekind C. International Union Against Cancer
(UICC) TNM classiﬁcation of malignant tumors , 7th Edition. New York: Wiley-Liss;
2010.
4. Ahn HS, Lee HJ, Hahn S, et al. Evaluation of the seventh American Joint
Committee on Cancer/International Union Against Cancer Classiﬁcation of gastric
adenocarcinoma in comparison with the sixth classiﬁcation. Cancer 2010;116:
5592–8.
5. Wang W, Sun X, Li C, et al. Comparison of the 6th and 7th editions of the UICC TNM
staging system for gastric cancer: results of a Chinese single-institution study of
1,503 patients. Ann Surg Oncol 2011;18:1060–7.
6. Rausei S, Dionigi G, Boni L, Rovera F, Dionigi R. How does the 7th TNM edition ﬁt in
gastric cancer management? Ann Surg Oncol 2011;18:1219–21.
7. Sobin LH,WittekindCH, editors. TNMClassiﬁcation ofmalignant tumors , 6th Edition.
New York: John Wiley & Sons; 2002.
8. Kwee RM, Kwee TC. Imaging in assessing lymph node status in gastric cancer.
Gastric Cancer 2009;12:6–22.
9. Sobin LH,Wittekind CH, editors. TNMclassiﬁcation ofmalignant tumors , 5th Edition.
New York: Wiley; 1997.
10. Fang WL, Huang KH, Chen JH, et al. Comparison of the survival difference between
AJCC 6th and 7th editions for gastric cancer patients. World J Surg 2011;35(12):
2723–9.
11. McGhan LJ, Pockaj BA, Gray RJ, Bagaria SP, Wasif N. Validation of the updated 7th
edition AJCC TNM staging criteria for gastric adenocarcinoma. J Gastrointest Surg
2012;16(1):53–61.
12. Qiu MZ, Wang ZQ, Zhang DS, et al. Comparison of 6th and 7th AJCC TNM staging
classiﬁcation for carcinoma of the stomach in China. Ann Surg Oncol 2011;18(7):
1869–76.
13. Jung H, Lee HH, Song KY, Jeon HM, Park CH. Validation of the seventh edition of
the American Joint Committee on Cancer TNM Staging System for gastric cancer.
Cancer 2011;117(11):2371–8.
14. Kikuchi S, Futawari N, Sakuramoto S, et al. Comparison of staging system between
the old (6th edition) and new (7th edition) TNM classiﬁcations in advanced gastric
cancer. Anticancer Res 2011;31:2361–5.
15. Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K. Outcome of ratio
of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 2002;9:775–84.
16. Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging
and survival after gastrectomy for gastric cancer: data from a large US-population
database. J Clin Oncol 2005;23:7114–24.
17. Inoue K, Nakane Y, Iiyama H, et al. The superiority of ratio-based lymph node
staging in gastric carcinoma. Ann Surg Oncol 2002;9:27–34.
18. WangW, XuDZ, Li YF, et al. Tumor-ratio-metastasis staging system as an alternative
to the 7th edition UICC TNM system in gastric cancer after D2 resection – results of
a single-institution study of 1343 Chinese patients. Ann Oncol 2011;22:2049–56.
19. Deng J, Liang H,Wang D. The feasibility of N stage of the 7th edition TNM for gastric
cancer. Ann Surg Oncol 2011;18:1805–6.
